IHR-1
产品说明书
 |
同义名 : | - |
| CAS号 : | 548779-60-8 | |
| 货号 : | A960663 | |
| 分子式 : | C20H12Cl4N2O2 | |
| 纯度 : | 99%+ | |
| 分子量 : | 454.13 | |
| MDL号 : | MFCD03404776 | |
| 存储条件： |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 20 mg/mL(44.04 mM)，配合低频超声，并水浴加热至45℃助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
| 生物活性 | |||
|---|---|---|---|
| 描述 | IHR-1 is a cell membrane impermeable Smo antagonist[1]. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03565614 | Rehabilitation by Recovery of ... 展开 >>Function 收起 << | Not Applicable | Enrolling by invitation | March 31, 2019 | Sweden ... 展开 >> Eskilstuna municipality, Care and social care service, Rehabilitation unit Eskilstuna, Södermanland, Sweden, 63343 收起 << |
| NCT01264003 | Inguinal Hernia | Phase 4 | Completed | - | - |
| NCT02424604 | - | Completed | - | Sweden ... 展开 >> Ersta Hospital Stockholm, Sweden, 116 91 收起 << | |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.20mL 0.44mL 0.22mL |
11.01mL 2.20mL 1.10mL |
22.02mL 4.40mL 2.20mL |
| 参考文献 |
|---|